Search results for "Activity"

showing 10 items of 7178 documents

On the anti-inflammatory and anti-phospholipase A2 activity of extracts from lanostane-rich species

2000

Abstract We have studied extracts from three species rich in lanostane triterpenes for their activity against different in vivo models of inflammation induced by TPA, EPP and PLA2. The inhibitory effect against PLA2 in vitro was also studied. When the Poria cocos extract was tested against PLA2-induced mouse paw edema, it was active by the oral and parenteral routes. Its effect was greater in both magnitude and duration than that of Pistacia terebinthus and Ganoderma lucidum extracts. P. terebinthus was effective against chronic and acute inflammation, and according to a preliminary chromatographic analysis, its seems to be a good source of lanostane anti-inflammatory agents. G. lucidum was…

medicine.drug_classGanodermaAnti-Inflammatory AgentsAdministration OralPharmacognosyPharmacologyPistacia terebinthusLanostanePhospholipases AAnti-inflammatoryMicechemistry.chemical_compoundDrug DiscoverymedicineAnimalsEdemaMedicinal fungiInfusions ParenteralInflammationPharmacologyAnalysis of VariancebiologyPistaciaPlant ExtractsBiological activitybiology.organism_classificationTriterpenesBiochemistrychemistryFemalelipids (amino acids peptides and proteins)Journal of Ethnopharmacology
researchProduct

Macrolides May Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Entry into Cells: A Quantitative Structure Activity Relationship Study and Exp…

2021

The global pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening the health and economic systems worldwide. Despite the enormous efforts of scientists and clinicians around the world, there is still no drug or vaccine available worldwide for the treatment and prevention of the infection. A rapid strategy for the identification of new treatments is based on repurposing existing clinically approved drugs that show antiviral activity against SARS-CoV-2 infection. In this study, after developing a quantitative structure activity relationship analysis based on molecular topology, several macrolide antibiotics are identified as promising SARS-…

medicine.drug_classGeneral Chemical EngineeringvirusesQuantitative Structure-Activity RelationshipDiseaseLibrary and Information Sciencesmedicine.disease_causeAzithromycin01 natural sciencesAntiviral AgentsVirusArticleMacrolide AntibioticsViral life cycleClarithromycin0103 physical sciencesPandemicmedicineHumansCoronavirus010304 chemical physicsbusiness.industrySARS-CoV-2COVID-19General ChemistryVirology3. Good health0104 chemical sciencesComputer Science ApplicationsAnti-Bacterial Agents010404 medicinal & biomolecular chemistryPharmaceutical PreparationsSpike Glycoprotein CoronavirusMacrolidesbusinessmedicine.drugJournal of Chemical Information and Modeling
researchProduct

General considerations in the interpretation of I-J genetic restrictions: evidence that the antigen-binding chain of antigen-specific T-suppressor fa…

1987

SUMMARY (CBA × B10)F1 [(H-2k x H-2b)] mice produce two types of antigen-specific T-suppressor factor (TsF), which can be separated by affinity chromatography on anti-I-J monoclonal antibody. After reduction and alkylation, both chains of F1 TsF are required for biological activity. However, the antigen-binding chain (AgBC) of F1 TsFk (AgBCk) is only complemented by I-Jk and likewise for F1 TsFb. In other words, interchain complementation shows the same genetic restriction in interchain complementation in parental and F1 mice. F1 TsF bearing, for example, I-Jk (TsFk), interacts with haptenized ‘antigen-presenting cells’ (‘APC’) of both parental haplotypes, and may be described as showing dua…

medicine.drug_classImmunologyAntigen-Presenting CellsImmunogeneticsBiologyMonoclonal antibodyModels BiologicalEpitopesMiceStructure-Activity RelationshipAntigenAffinity chromatographySpecies SpecificityGeneticsmedicineSuppressor Factors ImmunologicAnimalsBinding siteReceptorCrosses GeneticGeneticsBinding SitesHaplotypeGenetic Complementation TestHistocompatibility Antigens Class IIComplementationHaplotypesJournal of immunogenetics
researchProduct

C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids

1991

Using a monoclonal antibody directed against the C-chain of human C1q, we detected C1q-bearing immune complexes (IC) in sera and synovial fluids of rheumatoid arthritis (RA) patients. In a sandwich-ELISA, C1q-bearing IC were captured by the solid-phase monoclonal antibody and then detected with peroxidase-labeled F(ab')2-antibodies to either human IgG or IgM. The results of this assay were compared to an ELISA-modification of the C1q-solid-phase binding assay (C1q-SPBA). C1q-bearing IC were detected in 81.1% of RA-sera and the 65.2% of RA-synovial fluids. IgG as well as IgM was present in 72.6% of the sera and 70% of the synovial fluids which were positive in both assays. Most RA sera that …

medicine.drug_classImmunologyEnzyme-Linked Immunosorbent Assaychemical and pharmacologic phenomenaAntigen-Antibody ComplexMonoclonal antibodyComplement Hemolytic Activity AssayArthritis RheumatoidImmunoglobulin Fab FragmentsClassical complement pathwayImmune systemRheumatologyimmune system diseasesOsteoarthritisSynovial FluidmedicineHumansImmunology and AllergySynovial fluidskin and connective tissue diseasesbiologybusiness.industryComplement C1qAntibodies Monoclonalmedicine.diseaseImmune complexImmunoglobulin MImmunoglobulin GRheumatoid arthritisMonoclonalImmunologybiology.proteinAntibodybusinessRheumatology International
researchProduct

Reaction of 4-acylaminomethylpyridine N-oxides with phenylbutazone in the presence of acetic anhydride

1987

medicine.drug_classInfraredOrganic ChemistryCarboxamideBiological activityNuclear magnetic resonance spectroscopyAmine oxidechemistry.chemical_compoundAcetic anhydridechemistrymedicinePhenylbutazoneOrganic chemistrymedicine.drugJournal of Heterocyclic Chemistry
researchProduct

 A Mechanistic Approach to theIn VivoAnti-Inflammatory Activity of Sesquiterpenoid Compounds Isolated fromInula viscosa

2001

The present study was designed to examine the anti-inflammatory activity of the sesquiterpenoids ilicic acid and inuviscolide, isolated from Inula viscosa, on cell degranulation, leukotriene biosynthesis, neurogenic drive and glucocorticoid-like interactions. Swiss female mice were used to measure the ear oedema induced by phorbol esters or ethyl phenylpropiolate (EPP), and the paw oedema induced by phospholipase A(2) (PLA(2)) or serotonin. Drug treatment consisted of one topically-applied dose in the ear models and a subcutaneous or intraperitoneal injection in the paw models. Quantitative analysis of leukotriene B(4) (LTB(4)) formation was performed on rat peritoneal neutrophils by high p…

medicine.drug_classLeukotriene B4medicine.medical_treatmentIntraperitoneal injectionPharmaceutical SciencePharmacologyBiologyPharmacognosyLeukotriene B4Cell DegranulationAnti-inflammatoryAnalytical ChemistryInhibitory Concentration 50MiceStructure-Activity Relationshipchemistry.chemical_compoundPhospholipase A2In vivoDrug DiscoverymedicineAnimalsDrug InteractionsGlucocorticoidsInflammationPharmacologyPhospholipase ADose-Response Relationship DrugMolecular StructureAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryComplementary and alternative medicineBiochemistryMechanism of actionchemistrybiology.proteinMolecular MedicineFemaleInulaPlant Preparationsmedicine.symptomSesquiterpenesPhytotherapyPlanta Medica
researchProduct

In Vivo Studies on the Anti-Inflammatory Activity of Pachymic and Dehydrotumulosic Acids

2000

Pachymic and dehydrotumulosic acids were studied in different models of acute and chronic inflammation. They proved to be active in most of the methods applied. None of them were active against arachidonic acid-induced ear edema. Dehydrotumulosic acid significantly diminished the mouse ear edema induced by ethyl phenylpropiolate, while pachymic acid was ineffective. When the putative corticoid-like mechanism of both compounds was explored, pachymic acid activity was partially abolished by the glucocorticoid receptor antagonist progesterone, but dehydrotumulosic acid activity was not affected. In vivo experiments demonstrated the inhibition by both principles of the phospholipase A2 (PLA2)-i…

medicine.drug_classPharmaceutical SciencePharmacologyAnti-inflammatoryAnalytical ChemistryMicechemistry.chemical_compoundPhospholipase A2In vivoDrug DiscoverymedicineAnimalsPharmacologybiologyAntiglucocorticoidAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryFungiBiological activityTriterpenesExtravasationComplementary and alternative medicinechemistryBiochemistryMechanism of actionEnzyme inhibitorbiology.proteinMolecular MedicineFemalemedicine.symptomPlanta Medica
researchProduct

(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.

2015

Breast cancer remains the leading cause of cancer-related death among women. The invasive triple-negative subtype is unresponsive to estrogen therapy, and few effective treatments are available. In search of new chemical scaffolds to target this disease, we conducted a phenotypic screen against the human breast carcinoma cell lines MDA-MB-231, MA11, and MCF-7 using terrestrial natural products. Natural products that preferentially inhibited proliferation of triple-negative MDA-MB-231 cells over estrogen receptor-positive cells were further studied; herein we focused on the abietanes. The activity of the abietane carnosol prompted us to generate a focus library from the readily available (+)…

medicine.drug_classPhenotypic screeningApoptosisTriple Negative Breast NeoplasmsPharmacologyCarnosolchemistry.chemical_compoundStructure-Activity RelationshipBreast cancerCell Line TumorDrug DiscoverymedicineHumansTriple-negative breast cancerCell ProliferationPharmacologyBiological ProductsDose-Response Relationship DrugMolecular StructureCell growthDrug discoveryOrganic ChemistryStereoisomerismGeneral MedicineTriple Negative Breast Neoplasmsmedicine.diseaseAntineoplastic Agents PhytogenicchemistryEstrogenAbietanesMCF-7 CellsFemaleDrug Screening Assays AntitumorEuropean journal of medicinal chemistry
researchProduct

Kaempferol as a dietary anti-inflammatory agent: current therapeutic standing

2020

Inflammation is a physiological response to different pathological, cellular or vascular damages due to physical, chemical or mechanical trauma. It is characterized by pain, redness, heat and swelling. Current natural drugs are carefully chosen as a novel therapeutic strategy for the management of inflammatory diseases. Different phytochemical constituents are present in natural products. These phytochemicals have high efficacy both in vivo and in vitro. Among them, flavonoids occur in many foods, vegetables and herbal medicines and are considered as the most active constituent, having the ability to attenuate inflammation. Kaempferol is a polyphenol that is richly found in fruits, vegetabl…

medicine.drug_classPhytochemicalsAnti-Inflammatory AgentsPharmaceutical ScienceBiological AvailabilityReviewChemical FractionationAnti-inflammatoryAnalytical Chemistrylcsh:QD241-441therapeutic utility03 medical and health scienceschemistry.chemical_compoundStructure-Activity Relationship0302 clinical medicinelcsh:Organic chemistryDrug DiscoveryToxicity TestsmedicineAnimalsHumansPhysical and Theoretical ChemistryKaempferols030304 developmental biologyTherapeutic strategyFlavonoids0303 health sciencesBiological ProductskaempferolPlants MedicinalTraditional medicineOrganic Chemistryfood and beveragesKaempferol Anti-Inflammatory TherapyBioavailabilityReview articlechemistryPhytochemicalChemistry (miscellaneous)Polyphenolinflammation030220 oncology & carcinogenesisDietary SupplementsMolecular MedicineKaempferol
researchProduct

Benzodiazepines: specific competitors for the binding of L-tryptophan to human serum albumin.

1975

By means of the gel filtration technique, the effect of nine benzo-diazepine derivates on the binding of l-tryptophan to human serum albumin was investigated. Using equimolar tryptophan and benzodiazepine concentrations, all benzodiazepines with binding constants higher than 104 (M−1), displace l-tryptophan from its binding site to a high degree. The mechanism of the displacement was characterized as a competition for a common binding site. Some of the benzodiazepines displace l-tryptophan to a greater extent than salicylic acid. The benzodiazepines and tryptophan are the only substances known with a high degree of stereospecific binding to human serum albumin. This study shows that there i…

medicine.drug_classSerum albuminPlasma protein bindingBinding CompetitiveBenzodiazepinesStructure-Activity RelationshipmedicineStructure–activity relationshipAnimalsHumansBinding siteSerum AlbuminPharmacologyBenzodiazepineBinding SitesbiologyChemistryTryptophanTryptophanSerum Albumin BovineGeneral MedicineMetabolismHuman serum albuminSalicylatesBiochemistrybiology.proteinChromatography Gelmedicine.drugProtein BindingNaunyn-Schmiedeberg's archives of pharmacology
researchProduct